
| Revenue | $10 - $100 million See Exact Annual Revenue |
|---|---|
| Employees | 10 - 100Exact Company Size |
| Primary Industry | 5417 Scientific Research & Development Services |
| Additional NAICS Codes | 551112 Offices of Other Holding Companies |
| Address | 7400 State Line Rd Ste 202 Prairie Village, KS 66208 |
| Artio Medical | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | $10 - $100 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Artio Medical P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| ARTIO Medical apparatus, namely, external blood pump system for use in stimulating flow-mediated vein dilation; medical devices for the treatment of peripheral vascular, neurovascular, and structural heart diseases; Embolization systems comprising detachable balloon catheters and coils for use during brain aneurysm embolizations; Medical devices for the treatment of peripheral vascular diseases, namely, devices for peripheral artery and vein embolization and occlusion; detachable balloon medical devices for peripheral artery and vein embolization and occlusion for the treatment of peripheral vascular, neurovascular, and structural heart diseases | 05/10/2022 |
| TRIDENT Medical device for the treatment of peripheral vascular, neurovascular, and structural heart diseases, namely, a detachable balloon delivery system for artery and vein embolization and occlusion; Detachable delivery system comprising telescoping catheters and a mechanical latch to assist in the placement of a detachable balloon during peripheral vascular, neurovascular, and structural heart disease embolization and occlusion | 03/29/2022 |
| FOREFRONT catheters | 03/24/2022 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| LEIDOS | Denver, CO | 100 |
| NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 30 |
| INC RESEARCH | Raleigh, NC | 27 |
| RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
| FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
| SYNEOS HEALTH | Raleigh, NC | 13 |
| ILLUMINA | San Diego, CA | 12 |
| UT-BATTELLE | Oak Ridge, TN | 11 |
| PRA HOLDINGS | Raleigh, NC | 11 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| ALTASCIENCES CLINICAL KANSAS | Overland Park, KS | 100 |
| EMB STATISTICAL SOLUTIONS | Overland Park, KS | 2 |
| ARTIO MEDICAL | Prairie Village, KS | 2 |
| VENTRIA BIOSCIENCE | Shawnee Mission, KS | 2 |
| TECHACCEL LLC. | Overland. Park, KS | 2 |
| COLLECTIVE MEDICAL RESEARCH | Prairie Village, KS | 1 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |